Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7945167c7b90f65d7a6110dfddbeeee |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2012-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fb90cd3b28620cc1e43c8d4854a8bdb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17acd0a013a970f4b52d41e14140f521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24510230fa5dfb287f80e4f8d1c64a8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c962e8c4a1d734e46b901cdcb054571b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19d46aac9576541b11fc6e6e88682d58 |
publicationDate |
2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2012200253-A1 |
titleOfInvention |
Human protein tyrosine phosphatase inhibitors and methods of use |
abstract |
Case No. AU 2012200253 Abstract The present invention relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-) inhibitors thereby regulating angiogenesis. Such compounds are of the following formula wherein variables R and Z are as defined in the specification herein. The present invention further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-) inhibitors, and to methods for regulating angiogenesis. \S N |
priorityDate |
2006-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |